Company Data
Puma Biotechnology Inc
Ticker
PBYI
Current Price
$10.12 -1.65%
Market Cap
$522.4M
Price Target
Refer to Report
Volume
295.3K
52wk Range
$4.575 - $10.495
Overview
Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357.